YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YIHCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,532 | $3,442 | $3,338 | $3,064 |
| - Cash | $1,404 | $1,674 | $924 | $1,131 |
| + Debt | $2,235 | $2,609 | $3,822 | $3,194 |
| Enterprise Value | $4,364 | $4,377 | $6,236 | $5,127 |
| Revenue | $3,724 | $6,295 | $3,745 | $914 |
| % Growth | -40.8% | 68.1% | 309.8% | – |
| Gross Profit | $2,794 | $4,986 | $2,846 | $484 |
| % Margin | 75% | 79.2% | 76% | 52.9% |
| EBITDA | $1,070 | $2,745 | $691 | -$207 |
| % Margin | 28.7% | 43.6% | 18.5% | -22.6% |
| Net Income | $483 | $1,993 | $77 | -$588 |
| % Margin | 13% | 31.7% | 2% | -64.3% |
| EPS Diluted | 0.55 | 2.26 | 0.087 | -0.67 |
| % Growth | -75.7% | 2,494.7% | 113% | – |
| Operating Cash Flow | $89 | $1,673 | $1,700 | -$663 |
| Capital Expenditures | -$1,182 | -$595 | -$570 | -$356 |
| Free Cash Flow | -$1,093 | $1,078 | $1,130 | -$1,019 |